Related Articles
Comprehensive analysis of the expression and prognosis of YPEL family members in clear cell renal cell cancer
ENO2 affects the EMT process of renal cell carcinoma and participates in the regulation of the immune microenvironment
GSDMB: A novel, independent prognostic marker and potential new therapeutic target in clear cell renal cell carcinoma
Identification and validation of DLX4 as a prognostic and diagnostic biomarker for clear cell renal cell carcinoma
GBP2 promotes clear cell renal cell carcinoma progression through immune infiltration and regulation of PD‑L1 expression via STAT1 signaling